Skip to main content

Remifentanil

Location: 
Ghent University Hospital,Belgium

Remifentanil, an ultra-short acting synthetic opioid, is an important intraoperative analgesic agent.  Being able to reliably detect its physiological effect is an important step towards monitoring the analgesic state of a patient.  This study involved the reanalysis of electroencephalographic (EEG) data recorded during propofol-remifentanil anaesthesia and showed that the BAR methodology, unlike existing EEG monitoring approaches, was capable of differentiating the effects of the anaesthetic agent propofol from the analgesic agent remifentanil.

Anesthesiology - Editorial : Disentangling Hypnos from His Poppies

Anesthesiology Aug 2010: Propofol and Remifentanil Differentially Modulate Frontal Electroencephalographic Activity

 

AttachmentSize
Remifentanil Poster FINAL.pdf169.78 KB